Skip to main content
. 2017 Aug 22;8(42):72363–72374. doi: 10.18632/oncotarget.20390

Table 2. Development of cloned embryos derived from the normal imprinting donor cells treated with 5-aza-dC.

Group No. embryos (Rep.) No. embryos cleaved (% ± SEM) No. blastocysts (% ± SEM)
Aza (−) 135 (5) 118 (87.76 ± 1.39) 28 (22.95 ± 1.96)a
Aza (+) 157 (5) 127 (82.19 ± 1.65) 20 (15.40 ± 0.61)b

a–bValues in the same column with different superscripts differ significantly (P < 0.05).